Advertisement
Screener

BIO-TECHNE Corp (TECH) Cash Flow Breakdown

BIO-TECHNE Corp Cash Flow Breakdown

Cash flow breakdown shows where BIO-TECHNE Corp's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2026-06-30: from running the business, $292.07M came in.
  • Fiscal year ended 2026-06-30: from investing, $18.19M went out.
  • Fiscal year ended 2026-06-30: from financing, $169.11M went out.
  • Fiscal year ended 2026-06-30: change in cash, $102.53M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDividendsCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30$292.07M-$18.19M-$41.67M-$49.92M-$146.00M-$12.14M$80.62M$102.53M
2025-06-30$287.56M-$35.18M-$275.73M-$50.39M-$77.00M-$6.52M$51.74M$104.00M*$10.39M
2024-06-30$298.98M-$203.03M-$80.04M-$50.42M-$256.00M-$21.87M$60.94M$225.00M*-$28.78M
2023-06-30$254.39M-$265.65M-$19.56M-$50.28M-$525.66M-$28.89M$29.81M-$2.46M$619.66M*$8.00M
2022-06-30$325.27M-$96.85M-$160.95M-$50.19M-$175.50M-$23.46M$77.16M$788.00K$89.30M*-$26.52M
2021-06-30$352.16M-$243.52M-$43.18M-$49.62M-$271.50M-$19.34M$65.09M$256.00M*$52.47M
2020-06-30$205.22M$27.09M-$50.11M-$48.90M-$188.50M-$3.87M$70.98M$36.60M*$45.74M
2019-06-30$181.62M-$336.80M-$15.40M-$48.36M-$413.50M$37.95M-$6.30M$580.00M*-$21.10M
2018-06-30$170.37M-$38.71M$0.00-$47.97M-$59.50M$19.17M-$3.98M-$6.90M*$30.38M
2017-06-30$143.72M-$305.95M-$47.33M-$116.50M$5.26M-$503.00K*$348.18M*$27.38M
2016-06-30$144.16M-$107.57M-$47.61M-$58.50M$5.46M$279.00K*$77.00M*$9.71M
2015-06-30$139.36M-$426.49M$0.00-$47.11M$68.04M*$9.73M$615.00K-$264.04M
2014-06-30$136.76M$49.69M$0.00-$45.39M$0.00*$8.33M$262.00K$154.78M
2013-06-30$123.56M-$31.20M-$1.82M-$43.46M$0.00*$1.10M$75.00K*$47.11M
2012-06-30$126.75M-$21.67M-$23.60M-$41.02M$847.00K*$51.00K$39.06M
2011-06-30$127.19M-$114.19M-$1.94M-$39.69M$4.79M$847.00K-$16.53M
2010-06-30$111.26M-$114.61M-$14.97M-$38.39M$3.26M$196.00K*-$66.80M
2009-06-30$111.32M$21.28M-$90.63M-$28.19M$953.00K$107.00K-$1.68M*-$6.05M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDividendsDebt paid backNew debtCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30$95.42M*-$7.06M*-$41.65M*-$12.48M*$0.00*-$1.50M*$22.43M*
2026-03-31$86.66M*-$5.82M*$0.00*-$12.52M*-$60.00M*-$157.00K*$29.96M*
2025-12-31$82.41M*-$5.92M*$0.00*-$12.47M*-$40.00M*-$1.25M*$4.74M*
2025-09-30$27.59M$605.00K-$24.00K-$12.44M-$46.00M-$9.23M$23.50M-$17.22M
2025-06-30$98.20M*$406.00K*-$100.06M*-$12.39M*-$50.00M*-$234.00K*$6.23M*$66.00M*
2025-03-31$41.12M*-$8.87M*-$100.05M*-$12.58M*-$8.00M*-$291.00K*$14.87M*$38.00M*
2024-12-31$84.35M*-$5.03M*-$12.74M*$0.00*-$1.01M*$5.54M*-$75.63M*
2024-09-30$63.89M-$21.68M-$12.69M-$19.00M-$4.98M$25.10M$35.75M
2024-06-30$75.50M*-$8.81M*$0.00*-$12.63M*-$70.00M*-$402.00K*$22.93M*
2024-03-31$80.99M*-$16.44M*$0.00*-$12.58M*-$58.00M*-$168.00K*$18.33M*
2023-12-31$83.12M*-$23.67M*-$12.56M*-$58.00M*-$1.07M*$5.28M*-$15.04M*
2023-09-30$59.38M-$154.11M-$12.65M-$70.00M-$20.23M$14.39M$160.00M*-$31.91M
2023-06-30$83.39M*-$4.76M*$0.00*-$12.60M*-$20.00M*-$39.00K*$8.41M*$0.00*
2023-03-31$50.53M*-$241.10M*$0.00*-$12.58M*$0.00*-$11.00M*$4.42M*$0.00*$170.00M*
2022-12-31$64.38M*-$109.00K*$0.00*-$12.56M*-$64.66M*$0.00*$5.03M*$0.00*
2022-09-30$56.08M-$19.69M-$19.56M-$12.54M-$441.00M-$17.85M$11.95M-$2.46M$449.66M*-$7.31M
2022-06-30$102.72M*-$18.57M*-$58.82M*-$12.54M*-$3.13M*-$55.00K*$8.81M*$0.00*
2022-03-31$73.13M*-$35.99M*-$60.84M*-$12.58M*-$63.13M*-$159.00K*$11.85M*$24.04M*$16.75M*
2021-12-31$100.99M*-$35.17M*-$12.58M*-$58.13M*-$1.00K*$18.62M*-$1.00K*-$1.29M*
2021-09-30$48.43M-$7.12M-$12.49M-$51.13M-$23.25M$37.88M$9.30M*-$2.77M
2021-06-30$122.02M*-$226.90M*$0.00*-$12.45M*-$130.13M*$10.10M*-$5.84M*$256.00M*
2021-03-31$74.87M*$129.00K*-$43.18M*-$12.45M*$0.00*-$16.13M*$22.66M*-$6.13M*
2020-12-31$89.27M*-$8.60M*-$12.39M*-$92.13M*$16.92M*-$2.48M*
2020-09-30$66.01M-$8.14M-$12.34M-$33.13M$15.42M-$4.89M$22.78M
2020-06-30$44.79M*-$10.47M*$0.00*-$12.26M*-$63.13M*$32.49M*$1.57M*-$3.40M*
2020-03-31$49.47M*$19.36M*-$50.11M*-$12.28M*$40.00M*-$3.13M*$11.24M*-$3.51M*$45.92M*
2019-12-31$70.42M*$33.30M*-$12.20M*-$103.13M*$18.30M*-$1.00K*$10.40M*
2019-09-30$40.54M-$15.09M-$12.17M-$19.13M$8.95M-$1.93M-$995.00K
2019-06-30$55.95M*-$30.32M*$0.00*-$12.13M*-$17.13M*$10.92M*-$1.57M*$5.33M*
2019-03-31$39.66M*-$4.74M*-$1.00K*-$12.09M*-$23.13M*$8.17M*$0.00*$9.68M*
2018-12-31$46.56M*-$13.63M*-$12.09M*-$16.13M*$2.41M*-$3.00M*-$12.40M*-$8.79M*
2018-09-30$39.45M-$288.11M-$12.07M-$357.13M$580.00M-$357.13M$16.45M-$1.73M$354.12M*-$27.32M
2018-06-30$64.84M*$37.97M*-$12.03M*-$53.50M*$5.45M*$354.00K*-$3.10M*$35.38M*
2018-03-31$21.65M*-$57.93M*-$11.99M*$0.00*$7.03M*-$2.18M*$6.20M*-$34.85M*
2017-12-31$39.18M*-$6.34M*-$11.99M*$2.89M*-$355.00K*$25.00M*$48.99M*
2017-09-30$44.70M-$12.40M-$11.96M-$6.00M$3.81M-$1.80M-$35.00M*-$19.15M
2017-06-30$50.85M*-$4.70M*-$11.51M*$0.00*$1.63M*-$760.00K*-$6.00M*$31.77M*
2017-03-31$25.02M*$4.00K*-$11.94M*$0.00*$1.52M*-$86.00K*-$14.02M*$904.00K*
2016-12-31$41.18M*-$32.98M*-$11.94M*-$24.99M*$79.00K*-$10.65M*
2016-09-30$26.50M-$268.28M-$11.93M-$91.51M$2.03M$343.75M*$5.35M
2016-06-30$36.36M*-$3.62M*-$11.91M*-$24.00M*$3.54M*$327.00K*-$1.48M*
2016-03-31$37.14M*-$13.99M*-$11.90M*-$8.50M*$748.00K*$119.00K*$3.26M*
2015-12-31$38.54M*-$4.80M*-$11.90M*-$1.50M*$47.00K*-$11.00K*$13.61M*
2015-09-30$31.83M-$85.16M-$11.89M-$24.50M$1.13M$131.00K$77.00M*-$5.69M
2015-06-30$37.14M*-$5.52M*-$11.89M*-$74.01M*-$1.00K*$223.00K*-$51.91M*
2015-03-31$30.78M*-$3.15M*-$11.88M*-$1.95M*$2.70M*$134.00K*$13.48M*
2014-12-31$35.73M*-$63.07M*-$11.86M*-$6.00M*$5.17M*$180.00K*$38.00M*-$5.27M*
2014-09-30$35.72M-$354.75M-$11.47M-$13.00M$1.86M$78.00K$125.00M*-$220.33M
2014-06-30$37.92M*$163.69M*-$11.47M*$3.20M*$262.00K*$194.97M*
2014-03-31$34.93M*-$81.00K*-$11.44M*$1.57M*-$40.00K*$25.20M*
2013-12-31$31.32M*-$8.78M*-$11.43M*$2.42M*$36.00K*$14.55M*
2013-09-30$32.59M-$105.13M-$11.05M$1.15M$4.00K-$79.93M
2013-06-30$29.99M*-$4.76M*-$1.82M*-$11.05M*$281.00K*$6.00K*$13.07M*
2013-03-31$33.02M*-$11.53M*$0.00*-$11.05M*$0.00*$5.00K*$7.43M*
2012-12-31$31.29M*-$9.00M*$0.00*-$11.05M*$688.00K*$63.00K*$12.48M*
2012-09-30$29.26M-$5.92M$0.00-$10.31M$136.00K*$1.00K$14.13M
2012-06-30$37.41M*-$2.53M*-$2.31M*-$10.31M*$180.00K*$0.00*$21.39M*
2012-03-31$34.46M*-$7.86M*-$3.54M*-$10.32M*$622.00K*$38.00K*$14.29M*
2011-12-31$20.44M*-$829.00K*-$7.07M*-$10.36M*$0.00*$6.00K*$1.76M*
2011-09-30$34.43M-$10.45M-$10.68M-$10.03M$45.00K$7.00K-$907.00K*$1.62M
2011-06-30$34.67M*-$108.98M*$0.00*-$10.03M*$1.36M*$428.00K*-$81.02M*
2011-03-31$32.39M*-$2.63M*$0.00*-$10.02M*$0.00*$6.00K*$22.75M*
2010-12-31$29.43M*-$211.00K*$0.00*-$10.01M*$2.56M*$330.00K*$20.86M*
2010-09-30$30.70M-$2.37M-$1.94M-$9.63M$867.00K$83.00K$20.87M
2010-06-30$31.78M*-$21.03M*-$13.57M*-$9.69M*$222.00K*$19.00K*-$14.10M*
2010-03-31$23.22M*-$92.59M*-$1.40M*-$9.70M*$2.40M*$126.00K*-$87.31M*
2009-12-31$28.23M*$581.00K*-$9.69M*$612.00K*$41.00K*$20.79M*
2009-09-30$28.03M-$1.58M-$9.31M$22.00K$10.00K-$607.00K*$13.82M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Twist Bioscience Corp (TWST)United States$11.540B-47.21
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Immunovant, Inc. (IMVT)United States$7.028B-14.78